NCKAP1L

Nck-associated protein 1-like · P55160 · NCKAP1L on Sugi Atlas →

0 patent compounds predicted against NCKAP1L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NCKAP1L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion PHASE4RECRUITING
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy PHASE2COMPLETED
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] PHASE2UNKNOWN
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer PHASE2COMPLETED
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1COMPLETED
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy PHASE1COMPLETED
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease. PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods nanUNKNOWN
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
MYT1L Syndrome: a Rare Paediatric Genetic Syndrome Responsible for a Neurodevelopmental Disorder nanRECRUITING
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Exploring the Genetics of Neuropathic Pain nanRECRUITING
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia nanRECRUITING
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer nanACTIVE_NOT_RECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NCKAP1L binder may also engage these)

ProteinNameSimilarity
P55162 1.000 P55162 →
Q8K1X4 1.000 Q8K1X4 →
Q5SQX6 1.000 Q5SQX6 →
A7RU46 1.000 A7RU46 →
CYFIP1 Cytoplasmic FMR1-interacting protein 1 0.999 landscape →
Q6GQD1 0.997 Q6GQD1 →
Q90YM8 0.997 Q90YM8 →
Q7TMB8 0.997 Q7TMB8 →
P55163 0.995 P55163 →
Q640K3 0.994 Q640K3 →
Q5F3M0 0.994 Q5F3M0 →
NCKAP1 Nck-associated protein 1 0.993 landscape →
Q5R414 0.993 Q5R414 →
Q299G2 0.992 Q299G2 →
P55161 0.992 P55161 →
Q16X15 0.992 Q16X15 →
Q2PW47 0.991 Q2PW47 →
Q9VUY8 0.991 Q9VUY8 →
O44518 0.990 O44518 →
P28660 0.990 P28660 →
Q54IR8 0.989 Q54IR8 →
Q24134 0.989 Q24134 →
CYFIP2 Cytoplasmic FMR1-interacting protein 2 0.989 landscape →
Q9VF87 0.989 Q9VF87 →
B0S6R1 0.988 B0S6R1 →
Q6PI53 0.987 Q6PI53 →
A1CXW3 0.987 A1CXW3 →
Q9P2D8 0.987 Q9P2D8 →
Q29S00 0.986 Q29S00 →
Q4V8B3 0.986 Q4V8B3 →